Ehrlich Ascites Carcinoma (EAC) Cells' Lipopolysaccharide as Anti-Tumour Agent against EAC Cells

Jump To References Section

Authors

  • Department of Physics, Jadavpur University, Calcutta 700032 ,IN
  • Department of Physics, Jadavpur University, Calcutta 700032 ,IN
  • Guha Institute of Biochemistry, 55/5, Purna Das Road, Calcutta 700029 ,IN

DOI:

https://doi.org/10.18311/jsst/1992/2306

Keywords:

Ehrlich Ascites Carcinoma Cells, Lipopolysaccharide, Cancer Chemotherapy.

Abstract

In this study we have isolated and purified lipopolysaccharide (LPS) from Ehrlich Ascites Carcinoma (EAC) cells to find its therapeutic efficacy. Each preparation was checked for homogeneity by ultra-violet spectroscopy, infra-red spectroscopy and biochemical estimations. The lipopolysaccharide thus obtained was used to observe the regression of Ehrlich Ascites Carcinoma grown in vivo. The efficacy of lipopolysaccharide was found to be dose dependent.